DNA-guided CRISPR/Cas12 for RNA targeting

Carlos Orosco,Santosh R. Rananaware,Boyu Huang,Michael P. Hanna,M.Reza Ahmadimashhadi,Jordan G. Lewis,Michael P. Baugh,August P. Bodin,Sarah J. Flannery,Ian H. Lange,Zoe R. Fang,Vedant N. Karalkar,Katelyn S. Meister,Piyush K. Jain
DOI: https://doi.org/10.1101/2024.11.21.24317744
2024-11-22
Abstract:CRISPR-Cas nucleases are transforming genome editing, RNA editing, and diagnostics but have been limited to RNA-guided systems. We present ψDNA, a DNA-based guide for Cas12 enzymes, engineered for specific and efficient RNA targeting. ψDNA mimics a crRNA but with a reverse orientation, enabling stable Cas12-RNA assembly and activating trans-cleavage without RNA components. ψDNAs are effective in sensing short and long RNAs and demonstrated 100% accuracy for detecting HCV RNA in clinical samples. We discovered that ψDNAs can guide certain Cas12 enzymes for RNA targeting in cells, enhancing mRNA degradation via ribosome stalling and enabling multiplex knockdown of multiple RNA transcripts. This study establishes ψDNA as a robust alternative to RNA guides, augmenting the potential of CRISPR-Cas12 for diagnostic applications and targeted RNA modulation in cellular environments.
What problem does this paper attempt to address?
This paper aims to solve several key problems in RNA - targeting technologies, especially those related to RNA detection and regulation using the CRISPR/Cas12 system. Specifically, the researchers developed a DNA - based guide sequence (named ΨDNA) to guide the Cas12 enzyme to specifically recognize and cleave RNA. The following are the main objectives of this study: 1. **Develop a DNA - guided Cas12 enzyme system**: - The researchers designed ΨDNA, a DNA sequence that mimics crRNA but has a reverse arrangement, can stably bind to the Cas12 enzyme and activate its trans - cleavage activity without the need for an RNA component. - Through experimental verification, ΨDNA can efficiently detect short - and long - chain RNAs in vitro and in cells, and the accuracy rate of detecting HCV RNA in clinical samples reaches 100%. 2. **Improve the sensitivity and specificity of RNA detection**: - By optimizing the design of ΨDNA, the researchers improved its detection sensitivity and specificity for different RNA targets. For example, they tested ΨDNA of different lengths and different 3' - end stem - loop structures and found that ΨDNA with a 3' - end stem - loop has the highest detection activity. - Further research shows that specific atypical scaffold sequences can significantly improve the detection efficiency of ΨDNA, especially when using the AsCas12a enzyme. 3. **Achieve intracellular RNA regulation**: - The researchers demonstrated the ability of the ΨDNA - Cas12 complex to induce mRNA degradation through ribosome stalling in cells, thereby achieving inhibition of mRNA translation. - By conducting experiments in HEK293T cells, the researchers proved that the ΨDNA - Cas12 system can effectively knock down endogenous RNA transcripts, including the mRNA levels of genes such as PPIA, RPL4, and PCSK9. - In addition, the study also demonstrated the potential of this system in multiplex RNA knockdown, being able to target multiple RNA transcripts simultaneously, such as PPIA, RPL4, NRAS, and SMARCA4. 4. **Expand the application range of the CRISPR - Cas system**: - By developing a DNA - based guide sequence, the researchers provided a new tool for the CRISPR - Cas system, which can overcome the limitations of traditional RNA - guided sequences in terms of synthesis cost, stability, and operational complexity. - This technology is expected to be widely used in the fields of diagnosis and treatment, especially in applications that require efficient, specific, and stable RNA detection and regulation. In conclusion, this paper solves multiple key problems in RNA - targeting technologies by developing and optimizing the ΨDNA - Cas12 system, providing new possibilities for future biomedical research and applications.